Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of Multi-specific Antibodies Based on Immune Microenvironment of Breast Cancer

NCT05767931 is registered in ClinicalTrials.gov with Peking University as lead sponsor.

NCT NCT05767931
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05767931 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of Multi-specific Antibodies Based on Immune Microenvironment of Breast Cancer
Lead sponsor
Peking University
Phase
Observational
Overall status
Unknown status
Start date
March 6, 2023
Completion date
March 6, 2025
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

invasive breast cancer